Posted on

Production and efficacy testing of live attenuated and inactivated vaccines against experimental Salmonella Kentucky infection in broiler chickens

*1Igomu, E. E., 2Fagbamila, I. O., 3Elayoni, E. E., 1Pwajok, D., 1Agu, G. C., 4Govwang, P. F., 5Msheliza, E. G., 5Oguche, M. O., and 6Mamman, P. H.

*1Bacterial Vaccine Production Division, National Veterinary Research Institute, P.M.B. 01, Vom, Nigeria

2Bacterial Research Division, National Veterinary Research Institute, Vom, Nigeria

3Biological Science Department, Adamawa State University Mubi, Adamawa State, Nigeria

4Livestock Investigation Division, National Veterinary Research Institute, Vom, Nigeria

5Central Diagnostic Division, National Veterinary Research Institute, Vom, Nigeria 6Department of Veterinary Microbiology, Ahmadu Bello University, Zaria, Nigeria *Correspondence to: elayonigomu@gmail.com; +2348032786224

Abstract:
Background: Salmonella Kentucky is of great veterinary and public health concern and exhibits the capacities to emerge as the most prominent Salmonella serotype in human disease. The objective of this study is to evaluate the efficacy of prepared live attenuated and inactivated vaccines against experimentally induced salmonellosis caused by S. Kentucky in broiler chickens.

Methods: Field isolate of S. Kentucky was obtained from the National Veterinary Research Institute Vom, Nigeria and used in the preparation of experimental vaccines. Broiler chickens purchased and ascertained to be free of Salmonellae were randomly distributed into three experimental groups of 20 chicks each. Five-bromouracil at a concentration of 1000μg/ml was used in attenuation of S. Kentucky in preparation of the live vaccine and 0.6% formaldehyde was used in inactivation of S. Kentucky for preparation of the inactivated vaccine. Group 1 chicks were immunized with the live vaccine subcutaneously at 0.5ml per bird, group 2 received 1ml of the inactivated vaccine subcutaneously, and group 3 served as unvaccinated/control.

Results: There was 100% faecal inhibition and 100% vaccinal efficacy in broiler chickens immunized with the live vaccine on day 56 of age, and 49.6% faecal inhibition and 82.8% vaccinal efficacy in broiler chickens immunized with the inactivated vaccine on day 56 of age when compared with the unvaccinated control. The vaccinated birds also showed higher antibody (IgY) titre levels from day 21 to day 56 of age (p<0.001) on all sampling days when values were compared with the unvaccinated birds.

Conclusion: The interplay between vaccination protocol that includes administration of live attenuated or inactivated S. Kentucky vaccines and developed antibody (IgY) can reduce intestinal colonization by S. Kentucky and subsequent shedding of the serovar in faeces.

Keywords: Salmonella Kentucky, 5-bromouracil, IgY, Antibody, Vaccine

Received January 9, 2019; Revised April 11, 2020; Accepted April 12, 2020

Copyright 2020 AJCEM Open Access. This article is licensed and distributed under the terms of the Creative Commons Attrition 4.0 International License <a rel=”license” href=”//creativecommons.org/licenses/by/4.0/”, which permits unrestricted use, distribution and reproduction in any medium, provided credit is given to the original author(s) and the source.

Production et tests d’efficacité de vaccins vivants atténués et inactivés contre une infection expérimentale à Salmonella Kentucky chez des poulets de chair

*1Igomu, E. E., 2Fagbamila, I. O., 3Elayoni, E. E., 1Pwajok, D., 1Agu, G.C., 4Govwang, P. F., 5Msheliza, E. G., 5Oguche, M. O., et 6Mamman, P. H. Continue reading “Production and efficacy testing of live attenuated and inactivated vaccines against experimental Salmonella Kentucky infection in broiler chickens”

Posted on

Rubella IgG Antibody among Nigerian Pregnant Women without Vaccination History

MO Adewumi, RB Olusanya, BA Oladunjoye, JA Adeniji

 

Abstract

Rubella is a vaccine-preventable viral infection, its aetiologic agent; rubella virus was identified as human teratogen capable of causing a spectrum of birth defects described as congenital rubella syndrome (CRS). Despite the availability of safe and effective vaccines, significant proportion of the population remains susceptible to rubella infection in developing countries. More significantly, such developing countries including Nigeria have not demonstrated adequate commitment to preventive vaccination; a panacea for intervention. Consequently, this study was designed to determine the prevalence of anti-rubella IgG among pregnant women to ascertain the proportion of susceptible population. A total of 273 consenting rubella vaccine naïve antenatal clinic attendees aged 15-42 years (Median age = 28 years) were randomly selected and their sera analyzed for qualitative and quantitative anti-rubella IgG detection. Overall, 244/273 (89.4%) pregnant women enrolled in this study had protective level (Titre = >10 IU/mL) of anti-rubella IgG (Median Titre = 165 IU/mL; Range = <10 – >250 IU/mL), while, 29/273 (10.6%) of the study population lack protective antibody titre ( OD = <10 IU/mL). Results confirm previous reports of exposure, infection, and continuous circulation of rubella virus in Nigeria. It emphasizes the need for improved  and continuous surveillance for rubella and CRS cases, prompt vaccination of vulnerable populations, and evaluation of health policies to achieve immunization and ultimately ensure control/elimination of rubella virus in Nigeria and beyond.

Keywords: Rubella, Pregnancy, Antibody, Congenital Rubella Syndrome, Nigeria

Download full journal in PDF below

Rubella IgG Antibody among Nigerian Pregnant Women without Vaccination History

Posted on

Evaluation of immunity against poliovirus serotypes among children in riverine areas of Delta State, Nigeria

E Donbraye, MO Adewumi, GN Odaibo, AS Bakarey, OO Opaleye, DO Olaleye

 

Abstract

Nigeria remains one of the major reservoirs for wild poliovirus transmission despite the reported success in National Immunization Days and acute flaccid paralysis surveillance. Two hundred children aged ≤ 10 years, were enrolled following parental consent from hard-to-reach riverine areas of Delta state of Nigeria to assess the level of protective immunity to poliovirus. Neutralizing antibodies to the three poliovirus serotypes in the serum samples of the children were determined by the beta method of neutralization.
Eight (4%) of the children had no detectable antibody, 178 (89%), 180 (90%) and 181 (90.5%) were positive for antibodies to poliovirus types 1, 2 and 3, respectively. Overall, 162 (81%) of the children had antibodies to the three poliovirus serotypes at a titre of at least 1:8. The study shows the need for proper monitoring of vaccination coverage in such hard-to-reach riverine areas to achieve the objective of the global eradication of poliovirus.

Keywords: Neutralizing, antibody, poliovirus, serotypes, riverine, Nigeria

Download full journal in PDF below

Evaluation of immunity against poliovirus serotypes among children in riverine areas of Delta State Nigeria

Posted on

The pattern of the frequency of hbsag, hbeag, anti-hcv and anti-hbe in patients with haemoglobin genotype HbSS and HbSC in a rural community

MF Olaniyan

 

Abstract

Sixty HbSS sickle cell anaemic patients aged 17.45 ±10.1years (Female=30, Male=30) and sixty HbSC sickle cell disease patients aged 20.6±11.0years(Female=30,Male=30) were recruited for the investigation. Haemoglobin genotype of each of the patient was determined by electrophoresis. HepatitisB‘s’ antigen, HBeAg,anti-HBe, and anti-HCV in patients’ plasma were determined by Enzyme Immunoassay.
The frequencies of HBsAg, anti-HBe, HBeAg +HBsAg, HBsAg + antiHBe, in HbSS(6.7% , 20%,13.3%, and 20% respectively) were higher than those of HbSC( 5% ,8.3%, 5% , and 3.3% respectively). The frequency of anti-HCV + anti-HBe in HbSC was higher compared with that of HbSS patients ( 3.3% Vs 0%).The frequency of HBeAg in female HbSS and HbSC patients was higher than their male counterparts.( HbSS:16.7%Vs 10%;HbSC:6.7% Vs 3.3%).Higher frequency of HBsAg was found in HbSS male patients than the females (26.7% Vs 13.3%).The frequency of anti-HBe in HbSS male patients and HbSC female patients was higher than those of HbSS female patients and HbSC male patients respectively( HbSS:10% Vs 3.3%; HbSC: 10% Vs 6.7%).The frequency of HBeAg+ HBsAg obtained in HbSS male patients and HbSC female patients was higher than the results obtained from HbSS female patients and HbSC male patients (HbSS: 16.7% Vs 10%; HbSC:6.7% Vs 3.3%).The frequency of HBsAg + anti-HBe in HbSS female patients was higher than in HbSS male patients.(23.3% Vs 16.7%).None of the patients plasma was found to contain both HBeAg + anti-HBe. This research work has therefore been used to examine the pattern of HBeAg, HBsAg, anti-HCV, and anti-HBe in the plasma of patients with haemoglobin genotype HbSS and HbSC in rural community.

Keywords: Pattern, Frequency, HepatitisB, Hepatitis C, Antibody, Surface (‘s’) and Envelope (‘e’) antigens.

African Journal of Clinical and Experimental Microbiology Vol. 9 (2) 2008 pp. 82-87